Device Trial Radar · NCT05156112
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
194
Planned (sponsor's estimate)
Start
Jan 2, 2023
Primary completion
May 31, 2027
Study completion May 31, 2027
Sponsor
- Lead sponsor
- VA Office of Research and DevelopmentFederal agency
- Sponsor type
- Federal agency
- First posted
- Dec 14, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Substance use disorder (SUD) and posttraumatic stress disorder (PTSD) frequently co-occur and having both disorders is associated with greater psychological and functional impairment than having either disorder alone. This is especially true in residential settings where both disorders are more severe than outpatient settings. Obstructive sleep apnea (OSA) is highly comorbid with both disorders and untreated OSA is associated with worse functional impairment across multiple domains, worse quality of life, worse PTSD, higher suicidal ideation, and higher substance use and relapse rates. Treating OSA with evidence-based positive airway pressure (PAP) in Veterans with SUD/PTSD on a residential unit is a logical way to maximize treatment adherence and treatment outcomes. This study compares OSA treatment while on a SUD/PTSD residential unit to a waitlist control group. The investigators hypothesize that treating OSA on the residential unit, compared to the waitlist control, will have better functional, SUD, and PTSD outcomes.
Conditions
- Post Traumatic Stress Disorder
- Obstructive Sleep Apnea
- Substance Use Disorder
- Residential Treatment Program
Interventions
Positive Airway Pressure DeviceDevice
Each PAP treatment initiation meeting will include 1) mask fitting; 2) psycho-education to what to expect and reviewing PAP machine problem solving; and 3) setting up correct PAP treatment (e.g., auto PAP or in rare conditions, bi-level PAP).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)Time frame: Baseline, Post-SARRTP Unit (28 Days), 3-Month Follow up (90 Days)
- Change in Timeline Follow-Back (TLFB) % days drinking/using in last 90 daysTime frame: Baseline, 3-Month Follow up (90 Days)
- Change in Clinician Administered PTSD Scale (CAPS-5)Time frame: Baseline, Post-SARRTP Unit (28 Days), 3-Month Follow up (90 Days)
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
VA San Diego Healthcare System, San Diego, CA
San Diego, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.